Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

hepatocellular carcinoma

  • Open Access
    Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog
    SOOMIN KIM, YEJI KIM, SE EUN KIM and HA-JUNG KIM
    In Vivo January 2023, 37 (1) 252-261; DOI: https://doi.org/10.21873/invivo.13075
  • Open Access
    Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial
    YANG-CHENG LEE, WEN-TSUNG HUANG, MING-YANG LEE, CHAO-JUNG TSAO and YIN-HSUN FENG
    In Vivo January 2023, 37 (1) 454-460; DOI: https://doi.org/10.21873/invivo.13099
  • Open Access
    Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization and its Impact on Overall Survival
    MONIKA HAJKOVA, TOMAS ANDRASINA, PETRA OVESNA, TOMAS ROHAN, MAREK DOSTAL, VLASTIMIL VALEK, LENKA OSTRIZKOVA, STEPAN TUCEK, JIRI SEDO and IGOR KISS
    In Vivo September 2022, 36 (5) 2332-2341; DOI: https://doi.org/10.21873/invivo.12964
  • You have access
    The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma
    AKIYOSHI KINOSHITA, NORIKO HAGIWARA, AKIYUKI OSAWA, TAKAFUMI AKASU, YOSHIHIRO MATSUMOTO, KAORU UEDA, CHISATO SAEKI, TSUNEKAZU OIKAWA, KAZUHIKO KOIKE and MASAYUKI SARUTA
    In Vivo March 2022, 36 (2) 865-873; DOI: https://doi.org/10.21873/invivo.12775
  • You have access
    Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems
    HIRONOBU YANAGIE, MASASHI YANAGAWA, YASUYUKI MORISHITA, ATSUKO SHINOHARA, NOVRIANA DEWI, YASUMASA NONAKA, YOSHITAKA FURUYA, RYOUJI MIZUMACHI, YUUJI MURATA, HIROYUKI NAKAMURA, MINORU SUZUKI, YOSHINORI SAKURAI, HIROKI TANAKA, SHINICHIRO MASUNAGA, KOJI ONO, TAKUMICHI SUGIHARA, MASAYUKI NASHIMOTO, HARUO YAMAUCHI, MINORU ONO, JUN NAKAJIMA and HIROYUKI TAKAHASHI
    In Vivo November 2021, 35 (6) 3125-3135; DOI: https://doi.org/10.21873/invivo.12607
  • You have access
    COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
    SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN and ELENA LAURA ILIESCU
    In Vivo November 2021, 35 (6) 3377-3383; DOI: https://doi.org/10.21873/invivo.12636
  • You have access
    Lung Shunt Reduction for Yttrium-90 Radioembolization: Chemoembolization Versus Radioembolization
    HYO-CHEOL KIM, JIN WOO CHOI, MYUNGSU LEE, YOON JUN KIM, JIN CHUL PAENG and JIN WOOK CHUNG
    In Vivo July 2021, 35 (4) 2305-2312; DOI: https://doi.org/10.21873/invivo.12504
  • You have access
    Association Between Renal Adverse Effects and Mortality in Patients With Hepatocellular Carcinoma Treated With Lenvatinib
    YOSHINOSUKE SHIMAMURA, KOKI ABE, TAKUTO MAEDA, TAKESHI MATSUI, ATSUSHI ISHIGURO and HIDEKI TAKIZAWA
    In Vivo May 2021, 35 (3) 1647-1653; DOI: https://doi.org/10.21873/invivo.12423
  • You have access
    Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma
    MASAMICHI HAYASHI, SUGURU YAMADA, NAO TAKANO, YUKIYASU OKAMURA, HIDEKI TAKAMI, YOSHIKUNI INOKAWA, FUMINORI SONOHARA, NOBUTAKE TANAKA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MASAHIKO KOIKE and YASUHIRO KODERA
    In Vivo May 2021, 35 (3) 1749-1760; DOI: https://doi.org/10.21873/invivo.12434
  • You have access
    Progression After Molecular Targeted Agents: Hepatic Arterial Changes and Transarterial Chemoembolization in Hepatocellular Carcinoma
    NORITAKA MATSUDA, NORIHIRO IMAI, TEIJI KUZUYA, KENTA YAMAMOTO, TAKANORI ITO, YOJI ISHIZU, TAKASHI HONDA, MASATOSHI ISHIGAMI and MITSUHIRO FUJISHIRO
    In Vivo March 2021, 35 (2) 1185-1189; DOI: https://doi.org/10.21873/invivo.12367

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
In Vivo

© 2023 In Vivo

Powered by HighWire